Motif Neurotech
PrivateLast Round
Grant
Jan 20, 2025
Total Funding Raised
$24.75M
Company Overview
Motif Neurotech operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Grant round in January 2025.
Motif Neurotech is a biotechnology company that develops minimally invasive bioelectronic systems for treating treatment-resistant depression through innovative wireless power and data technologies.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical Devices, Biotechnology, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Motif Neurotech Comparables
Compare Motif Neurotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inner Cosmos | 85% | |
| Starfish Neuroscience | 82% | |
| Cenexum Technologies | 81% |
For institutional investors. Book with your work email.
Motif Neurotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 20, 2025 | ||||
| Series A | Jan 24, 2024 | ||||
| Accelerator | Feb 27, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Motif Neurotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | Series A |
| Arboretum Ventures | Series A |
| re.Mind Capital | Series A |
| Capital Factory | Series A |
| Advanced Research and Invention Agency | Grant |
| Texas Medical Center | Series A |
| Empath Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 14, 2025
Developing a neurostimulator system for severe depression treatment.
- Jan 20, 2025
Secured $6M in grant funding.
For institutional investors. Book with your work email.
Motif Neurotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Motif Neurotech's valuation, stock price, and market status.
Is Motif Neurotech a public or private company?
Motif Neurotech is a private company.
What is the current stock price of Motif Neurotech?
Motif Neurotech is a private company, so its shares have no public market price. Caplight tracks Motif Neurotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Motif Neurotech worth (valuation)?
Valuation information for Motif Neurotech is not publicly available.
Can I buy Motif Neurotech stock?
Motif Neurotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Motif Neurotech's last funding round?
Motif Neurotech's most recent funding round was Grant on January 20, 2025.
Who are the main investors in Motif Neurotech?
Key investors in Motif Neurotech include Arboretum Ventures.
Will Motif Neurotech IPO soon?
No public IPO plans have been announced for Motif Neurotech.
How can I track Motif Neurotech secondary market activity?
Caplight tracks bids, offers, and trades in Motif Neurotech's shares on secondary markets.